HER2 Positive Breast Cancer Market is driven by Targeted Therapies

a adăugat un sunet Health

2025-04-25 13:15:01 -

The HER2‑Positive breast cancer market centers on diagnostic tools and therapeutic agents that target the human epidermal growth factor receptor 2 (HER2), overexpressed in roughly 20% of breast cancer cases. Key products include monoclonal antibodies (trastuzumab, pertuzumab), antibody‑drug conjugates (ado‑trastuzumab emtansine, fam‑trastuzumab deruxtecan), and emerging biosimilars. These...

0 Commentarii 0 Distribuiri 770 Views 0 previzualizare